Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Centrum NCCN sa snaží vylepšiť globálnu onkologickú starostlivosť o deti pomocou novo preložených odporúčaní
  • Latin America - español
  • Brazil - Português
  • USA - Pусский
  • USA - čeština
  • USA - español
  • USA - Deutsch
  • USA - Français
  • USA - Polski
  • India - English
  • USA - English

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Jun 17, 2020, 02:35 ET

Share this article

Share toX

Share this article

Share toX

Pokyny NCCN pre detskú akútnu lymfoblastickú leukémiu v čínštine, japončine, francúzštine, španielčine a portugalčine sú teraz k dispozícii zadarmo na NCCN.org

PLYMOUTH MEETING, Pennsylvania, 17. júna 2020 /PRNewswire/ -- National Comprehensive Cancer Network® (NCCN®) - aliancia popredných onkologických centier v Spojených štátoch - oznamuje vydanie preložených verzií smerníc NCCN® pre detskú akútnu lymfoblastickú leukémiu (ALL) do čínštiny, francúzštiny, japončiny, portugalčiny a španielčiny. Detská ALL je najbežnejším typom rakoviny u detí, ale pri liečbe súčasnými prístupmi založenými na dôkazoch je vysoko liečiteľná.1 Usmernenia NCCN sú napísané a aktualizované vedúcimi orgánmi v rôznych zdravotných odboroch. Zahŕňajú najkomplexnejšie a najaktuálnejšie odporúčania na liečbu pacientov, vrátane detí s rakovinou mimo klinického skúšania.

Continue Reading
NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia translations in Chinese, French, Japanese, Portuguese, and Spanish
NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia translations in Chinese, French, Japanese, Portuguese, and Spanish

„Viac mladých životov by mohlo byť zachránených prostredníctvom široko dostupnej liečby založenej na dôkazoch," povedal Robert W. Carlson, MD, generálny riaditeľ NCCN. „Pokroky v boji proti detskej ALL boli v posledných rokoch pozoruhodné. Mieru vyliečenia môžeme ešte viac zlepšiť tým, že sa osvedčené postupy dostanú do všetkých kútov zeme. K dosiahnutiu tohto cieľa sa priblížime tak, že Usmernenia NCCN založené na konsenze urobíme prístupnejšie pre ľudí, ktorý nehovoria anglicky."

Anglická verzia usmernení NCCN pre detskú ALL bola prvýkrát uverejnená v máji 2019. Odporúčania sa týkajú typických liečebných algoritmov, napríklad režimov chemoterapie s viacerými činidlami, ako aj nových inovácií v cielenej terapii a chimérickej antigénovej receptorovej (CAR) T-bunkovej terapii, ktorá je druhom imunoterapie. Pokyny sú určené na manažment pacientov od narodenia cez dospievanie až do rannej dospelosti.

„Tieto smernice NCCN zahŕňajú silné zameranie na podpornú starostlivosť s cieľom znížiť potenciálne nebezpečné vedľajšie účinky u detí podstupujúcich liečbu," vysvetlil Dr. Carlson. „Pomáhajú tiež identifikovať zraniteľnú časť populácie, ako sú dojčatá alebo pacienti s Downovým syndrómom, a poskytujú konkrétne odporúčania na ich čo najbezpečnejšiu, krátkodobú aj dlhodobú ochranu."

Preložené pokyny sú k dispozícii bezplatne na nekomerčné použitie na NCCN.org/global alebo prostredníctvom funkcie Virtuálna knižnica v aplikácii NCCN Guidelines®.

Globálne oddelenie NCCN neustále aktualizuje a rozširuje úpravy a preklady usmernení NCCN pre všetky hlavné typy rakoviny plus podpornú starostlivosť a prevenciu. Len v tomto roku bolo uverejnených viac ako 40 nových prekladov vrátane klinických usmernení a verzií vhodných pre pacientov. NCCN poskytuje aj rámec NCCN Framework na stratifikáciu zdrojov podľa smerníc NCCN (NCCN Framework™) a smernice NCCN Harmonized Guidelines™ s optimálnymi odporúčaniami popri pragmatických prístupoch na prispôsobenie zaobchádzania v prostrediach s obmedzenými zdrojmi, ako sú krajiny s nízkymi a strednými príjmami. Navštívte stránku AlliedAgainstCancer.org, kde sa dozviete viac o prebiehajúcej práci NCCN v subsaharskej Afrike s Africkou koalíciou pre rakovinu (African Cancer Coalition), Americkou spoločnosťou pre rakovinu (American Cancer Society), iniciatívou Clinton Health Access Initiativea so spoločnosťou IBM.

Počas pandémie COVID-19 sú k dispozícii bezplatné odporúčania pre starostlivosť o seba a starostlivosť o pacientov s rakovinou, ošetrovateľov a poskytovateľov v angličtine, čínštine a španielčine na adrese NCCN.org/covid-19.

Navštívte stránku NCCN.org/global, kde nájdete viac informácií o všetkom, čo organizácia robí pre zlepšenie starostlivosti o rakovinu na celom svete, a pripojte sa ku konverzácii online pomocou kódu hashtag #NCCNGlobal.

O Národnej sieti pre rakovinu (National Comprehensive Cancer Network)
The National Comprehensive Cancer Network® (NCCN®) je nezisková aliancia popredných onkologických centier, ktoré sa venujú starostlivosti o pacientov, výskumu a vzdelávaniu. NCCN sa venuje zlepšovaniu a uľahčovaniu kvalitnej, efektívnej a dostupnej liečby rakoviny, aby pacienti mohli žiť lepšie. Pokyny NCCN pre klinickú prax v onkológii (smernice NCCN®) poskytujú transparentné odporúčania odborníkov založené na dôkazoch pre liečbu rakoviny, prevenciu a podporné služby; sú uznávaným štandardom klinického smerovania a politiky v oblasti liečby rakoviny a najpodrobnejšou a najaktuálnejšou smernicou pre klinickú prax, ktorá je k dispozícii v akejkoľvek oblasti medicíny. Pokyny NCCN pre pacientov® poskytujú odborné informácie o liečbe rakoviny a sú určené na informovanie a posilnenie postavenia pacientov a opatrovateľov prostredníctvom podpory od nadácie NCCN Foundation®. NCCN tiež podporuje ďalšie vzdelávanie, globálne iniciatívy, politiku a výskumnú spoluprácu a publikovanie v onkológii. Navštívte stránku NCCN.org, kde nájdete ďalšie informácie, a sledujte NCCN na sieťach Facebook @NCCNorg, Instagram @NCCNorg a Twitter @NCCN.

1 Esparza SD, Sakamoto KM, Topics in pediatric leukemia-acute lymphoblastic leukemia. MedGenMed 2005;7:23. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16369328. Ma H, Sun H Sun X. Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep 2014;4:4227. Dostupné na: https://www.ncbi.nlm.nih.gov/pubmed/24572378.

Kontakt pre médiá:
Rachel Darwin
267-622-6624
[email protected] 

Foto - https://mma.prnewswire.com/media/1180364/NCCN_Pediatric_Acute_Lymphoblastic_Leukemia_translations.jpg

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

Related Links

http://www.nccn.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven...

Renuka Iyer, MD, nommée directrice médicale du National Comprehensive Cancer Network (NCCN)

Renuka Iyer, MD, nommée directrice médicale du National Comprehensive Cancer Network (NCCN)

Le National Comprehensive Cancer Network® (NCCN®)-une alliance de centres de cancérologie de premier plan qui publie gratuitement des lignes...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.